Cito Capital Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Cito Capital Group, LLC

$268 Million
Q3 2024

A detailed history of Cito Capital Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cito Capital Group, LLC holds 2,040 shares of REGN stock, worth $1.51 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

2,040

Previous 1,540 32.47%

Holding current value

$1.51 Million

Previous $1.62 Million 32.49%

% of portfolio

0.8%

Previous 0.63%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $512,044 - $600,880	500 Added 32.47%	2,040 $2.15 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $441,600 - $535,595	500 Added 48.08%	1,540 $1.62 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $4,900 - $5,812	-7 Reduced 0.67%	1,040 $747,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $4,763 - $5,788	7 Added 0.67%	1,047 $860,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $573,970 - $724,320	-1,000 Reduced 49.02%	1,040 $716,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $274,175 - $369,420	-500 Reduced 19.69%	2,040 $1.21 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $304,348 - $375,743	-560 Reduced 18.06%	2,540 $1.6 Million
Q3 2021 Nov 10, 2021	SELL	$574.03 - $680.96 $287,015 - $340,480	-500 Reduced 13.89%	3,100 $1.88 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $41,019 - $47,758	-150 Reduced 4.0%	3,600 $999,000
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $29,960 - $41,482	100 Added 2.74%	3,750 $1.17 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $52,671 - $61,276	150 Added 4.29%	3,650 $1.48 Million
Q2 2018 Jul 03, 2018	BUY	$284.6 - $344.99 $284,600 - $344,990	1,000 Added 40.0%	3,500 $1.21 Million
Q4 2017 Feb 12, 2018	BUY	$358.63 - $469.95 $358,630 - $469,950	1,000 Added 66.67%	2,500 $0
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $647,070 - $756,000	1,500	1,500 $0

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cito Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cito Capital Group, LLC with notifications on news.

Account

Cito Capital Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History